Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
Authors
Keywords
Pancreatic cancer, Cancer treatment, Phosphorylation, Cancer cell migration, Small interfering RNAs, Ionizing radiation, Transcription factors, Cyclins
Journal
PLoS One
Volume 8, Issue 2, Pages e55289
Publisher
Public Library of Science (PLoS)
Online
2013-02-09
DOI
10.1371/journal.pone.0055289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
- (2015) Richard L. Watson et al. NEOPLASIA
- An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
- (2012) Katsuyoshi Miyashita et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
- (2011) Takeo Shimasaki et al. JOURNAL OF GASTROENTEROLOGY
- Guanine nucleotide exchange factors for RhoGTPases: Good therapeutic targets for cancer therapy?
- (2010) Galit Lazer et al. CELLULAR SIGNALLING
- Glycogen synthase kinase 3 in the world of cell migration
- (2010) Tong Sun et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
- (2009) Shadi Mamaghani et al. BMC CANCER
- Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells
- (2009) Beatrix Hage et al. Cell Communication and Signaling
- Potential Therapeutic Effect of Glycogen Synthase Kinase 3 Inhibition against Human Glioblastoma
- (2009) K. Miyashita et al. CLINICAL CANCER RESEARCH
- Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase
- (2009) W. Mai et al. CLINICAL CANCER RESEARCH
- Targeting protein kinases in central nervous system disorders
- (2009) Laura K. Chico et al. NATURE REVIEWS DRUG DISCOVERY
- The Role of Nuclear Factor κB in Pancreatic Cancer and the Clinical Applications of Targeted Therapy
- (2009) Bryan Holcomb et al. PANCREAS
- GSK3β Regulates Differentiation and Growth Arrest in Glioblastoma
- (2009) Serdar Korur et al. PLoS One
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
- Maintenance of Constitutive I B Kinase Activity by Glycogen Synthase Kinase-3 / in Pancreatic Cancer
- (2008) W. Wilson et al. CANCER RESEARCH
- Improving Gemcitabine-Mediated Radiosensitization Using Molecularly Targeted Therapy: A Review
- (2008) M. A. Morgan et al. CLINICAL CANCER RESEARCH
- Lamellipodia and filopodia in metastasis and invasion
- (2008) Laura M. Machesky FEBS LETTERS
- Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside
- (2008) Toru Furukawa JOURNAL OF GASTROENTEROLOGY
- Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
- (2008) Zhong Wang et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now